Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children
NCT ID: NCT01361347
Last Updated: 2017-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
28 participants
INTERVENTIONAL
2008-02-29
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacological Modulations of Allergen-Specific Immunotherapy
NCT00504946
High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety
NCT04415593
Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study
NCT06976775
High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety
NCT05158413
Randomized Controlled Trial of Slow Multiallergen Oral Immunotherapy in Young Children
NCT06533462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Age 6 - 16 yrs
* IgE-mediated milk allergy
* and milk provocation within 3 months prior to or an documented accidental milk contact with clear immediate symptoms
Outcome measures:
* number of patients with successful desensitization (195 - 200 ml milk per day)
* number of patients with adverse events
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
rice/soy/oat "milk"drink, masked
milk
milk for milk allergic children (1:25 dilution, whole milk)
milk
cow's milk
milk
milk for milk allergic children (1:25 dilution, whole milk)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
milk
milk for milk allergic children (1:25 dilution, whole milk)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* An immediately positive challenge test result to milk prior to inclusion
Exclusion Criteria
6 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marita Paassilta
MD, PhD, Paediatric Allergist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marita Paassilta, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Consultant Pediatric Allergist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital, Allergy Centre
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PaassiltaM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.